Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
VHAQ.WS was delisted on the 23rd of October, 2023.
32 hedge funds and large institutions have $4.32M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
2% more capital invested
Capital invested by funds: $4.22M → $4.32M (+$98K)
3% less funds holding
Funds holding: 33 → 32 (-1)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$131 |
| 2 |
HF
HRT Financial
New York
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$531 |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$331 |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$214 |
| 4 |
CS
Clear Street
New York
|
-$151 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$92 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PFM
26
Privium Fund Management
Amsterdam,
Netherlands
| $1.11K | – | – | – |
|
|
27
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $620 | -$331 | -15,382 | -39% |
|
|
HHGC
28
Hunting Hill Global Capital
New York
| $482 | – | – | – |
|
|
SCM
29
Saba Capital Management
New York
| $377 | – | – | – |
|
|
WAM
30
Wolverine Asset Management
Chicago,
Illinois
| $292 | – | – | – |
|
|
31
UBS Group
Zurich,
Switzerland
| $1 | -$92 | -4,287 | -99% |
|
|
32
Citadel Advisors
Miami,
Florida
| – | -$214 | -10,652 | Closed |
|
|
FTUS
33
Flow Traders U.S.
New York
| – | +$131 | +6,097 | +46% |
|
VHAQ.WS Hedge Fund Activity: Q3 2023 in Review
32 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q3 2023, worth a combined $4.32M — up 2.3% from $4.22M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of VHAQ.WS and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.
The largest buyer was Flow Traders U.S., adding an estimated $131. The largest seller was K2 Principal Fund, cutting an estimated $531.
- 32 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q3 2023, down from 33 in Q2 2023.
- Funds reported $4.32M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q3 2023, up 2.3% quarter-over-quarter.
- 0 funds opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q3 2023 and 1 closed out, a net change of -1 holder.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q3 2023 was Flow Traders U.S., an estimated $131 added.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q3 2023 was K2 Principal Fund, an estimated $531 sold.
Based on aggregated 13F filings for Q3 2023.